Lucence Presents New Data on Liquid Biopsy for Late-Stage Cancer Monitoring, Treatment Guidance
Genomeweb,
NEW YORK – Precision oncology assay developer Lucence has shared new real-world validation data from two Asian cohorts that it…
NEW YORK – Precision oncology assay developer Lucence has shared new real-world validation data from two Asian cohorts that it…
NEW YORK – Precision oncology assay developer Lucence has shared new real-world validation data from two Asian cohorts that it…
A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant "driver…
Return to Article List Next Article > Blood-Based Cancer Tests Reveal Complex Genomic Landscape of Non-Small Cell Lung Cancers…
Lung cancer cells invade surrounding tissues and start to spread. Image courtesy of the National Cancer Institute A new UC San…
Author Information (click to view) University of California - San Francisco University of California - San Francisco (click to…
Cancer treatments have moved much beyond the conventional surgery, radiotherapy and chemotherapy.
A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant “driver…
Information contained on this page is provided by an independent third-party content provider.
A new UC San Francisco-led study challenges the dogma in oncology that most cancers are caused by one dominant "driver…
Information contained on this page is provided by an independent third-party content provider.
REDWOOD CITY, Calif., Nov. 6, 2017 /PRNewswire/ -- Research led by scientists at UC San Francisco and the Francis Crick…
REDWOOD CITY, Calif., Nov. 6, 2017 /PRNewswire/ -- Research led by scientists at UC San Francisco and the Francis Crick…
Database Reveals Potential of Targeted Therapy Combinations to Treat Advanced Lung Cancer REDWOOD CITY, Calif., Nov.
A new UC San Francisco-led study challenges the dogma in oncology that most cancers are caused by one dominant "driver…
A new UC San Francisco-led study challenges the dogma in oncology that most cancers are caused by one dominant "driver…